drugset / Trial / NCT04597970
TACE Plus HAIC With Oxaliplatin and Raltitrexed for BCLC Stage C HCC
NaSingle-groupOpen-labelTreatment
Summary
Purpose：explore the effectiveness and safety of transarterial chemoembolization (TACE) plus Hepatic Arterial Infusion Chemotherapy (HAIC) with oxaliplatin and raltitrexed for Barcelona stage C hepatocellular carcinoma (HCC)
Timeline
- Start
- 2020-10-20
- Primary completion
- 2021-10-20
- Completion
- 2022-10-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxaliplatin | Small molecule | — | Other |
| Subject | Raltitrexed | Small molecule | — | Other |